Literature DB >> 12374239

Steroidal management and serum cytokine profile of a case of alcoholic hepatitis with leukemoid reaction.

C Argüelles-Grande1, F Leon, J Matilla, J Domínguez, J Montero.   

Abstract

Leukemoid reactions (LRs) are rare in alcoholic hepatitis (AH), but they are a sign of poor prognosis. The treatment of AH with corticosteroids is controversial, though several reports suggest that these should be used in severe cases of AH. We report a case of AH-associated LRs that presented with an increase of the serum concentrations of the proinflammatory cytokines interleukin (IL)-18 (an initiator of inflammation) and IL-1beta (likely responsible for the neutrophilia of the LRs). These findings provided a pathogenic indication for the use of corticosteroids (that block the transcription of IL-1beta), and this approach achieved a clinical and analytical recovery in our patient. This pathogenic mechanism might also underlie other cases of LRs and other complications of AH, thus providing a rationale for the benefits of corticotherapy in these rare but severe conditions.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12374239     DOI: 10.1080/003655202320378347

Source DB:  PubMed          Journal:  Scand J Gastroenterol        ISSN: 0036-5521            Impact factor:   2.423


  3 in total

1.  Alcoholic hepatitis with leukemoid reaction after surgery.

Authors:  Angel M Morales; Luis A Hashimoto; David Mokhtee
Journal:  J Gastrointest Surg       Date:  2006-01       Impact factor: 3.267

2.  Spontaneous remission of acute myeloid leukemia with NF1 alteration.

Authors:  Terrence Bradley; Radames Adamo Zuquello; Luis E Aguirre; Nicholas Mackrides; Jennifer Chapman; Luisa Cimmino; Amber Thomassen; Justin Watts
Journal:  Leuk Res Rep       Date:  2020-05-16

3.  Rare Case of Leukemoid Reaction in a Patient With Severe Alcoholic Hepatitis.

Authors:  Ted George O Achufusi; Anuj Sharma; Bishnu Sapkota; Kanish Mirchia
Journal:  Cureus       Date:  2020-08-14
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.